Product image of Leptoprol (Leuprorelin) supplied by GNH India

Leptoprol

Active Ingredient:
Leuprorelin
Origin:
EU

Leptoprol (Leuprorelin)

Leuprorelin, the active ingredient in Leptoprol, is a GnRH agonist presented as a sterile solution for subcutaneous use. It is employed in hormone therapy to manage prostate cancer, breast cancer, endometriosis, uterine fibroids and precocious puberty by suppressing sex steroid production.

GNH India supplies Leptoprol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide, ensuring quality and regulatory compliance across global markets with robust cold‑chain logistics and dedicated technical support for all product batches.

Manufacturer / TM Owner

Sandoz Pharmaceuticals D.D.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Leuprorelin is a GnRH agonist used in hormone‑dependent disease pathways to achieve medical castration or hormonal suppression.

  • Prostate cancer: reduces testosterone levels to slow tumor growth.
  • Breast cancer (hormone‑responsive): lowers estrogen production to inhibit tumor progression.
  • Endometriosis: suppresses estrogen to alleviate pelvic pain and lesion growth.
  • Uterine fibroids: decreases estrogen stimulation, leading to fibroid shrinkage.
  • Precocious puberty: blocks premature gonadotropin release to delay sexual maturation.

How It Works

  • Leuprorelin is a synthetic analogue of gonadotropin‑releasing hormone that initially stimulates pituitary GnRH receptors, causing a transient rise in LH and FSH. Continued exposure leads to receptor down‑regulation and desensitisation, markedly reducing LH and FSH secretion. The consequent decline in gonadal steroidogenesis lowers circulating testosterone and estrogen levels, providing therapeutic hormonal suppression.

Side Effects

Leuprorelin may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects

  • Hot flashes: sudden feeling of warmth and sweating.
  • Injection site reactions: redness, pain or swelling at the subcutaneous site.
  • Headache: mild to moderate intensity.
  • Fatigue: general tiredness or lack of energy.
  • Decreased libido: reduced sexual desire.
  • Mood changes: irritability or depressive symptoms.

Serious or Rare Side Effects

  • Cardiovascular events: hypertension, thromboembolic phenomena.
  • Severe allergic reaction: anaphylaxis, angioedema.
  • Bone mineral density loss: increased risk of osteoporosis with long‑term use.
  • Pituitary apoplexy: rare hemorrhage within the pituitary gland.

Precautions & Warnings

Leuprorelin therapy requires careful monitoring and patient education.

  • Hormone level monitoring: assess testosterone or estradiol periodically to confirm suppression.
  • Bone health assessment: evaluate bone mineral density and consider calcium/vitamin D supplementation.
  • Cardiovascular risk screening: monitor blood pressure, lipid profile, and signs of thrombosis.
  • Contraindication in pregnancy: avoid use in pregnant women due to fetal risk.
  • Use in pediatric patients: only under specialist supervision for precocious puberty.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

Leuprorelin can interact with other agents that influence hormonal balance or drug metabolism.

Major Interactions (Avoid)

  • Estrogen replacement therapy: may counteract the intended hormonal suppression.
  • High‑dose corticosteroids: can interfere with GnRH receptor down‑regulation.

Moderate Interactions (Monitor Closely)

  • CYP450 inducers (e.g., rifampicin): may reduce efficacy of concomitant hormonal agents.
  • Anticoagulants: monitor coagulation parameters as hormonal changes can affect clotting risk.
  • Antidepressants (SSRIs): may exacerbate mood‑related side effects.

Frequently Asked Questions

Leptoprol contains leuprorelin, a GnRH agonist indicated for hormone‑dependent conditions such as prostate cancer, hormone‑responsive breast cancer, endometriosis, uterine fibroids, and precocious puberty. It works by suppressing the production of sex steroids that drive disease progression.

Leuprorelin mimics natural GnRH, initially stimulating pituitary release of LH and FSH, then causing receptor down‑regulation. This leads to a sustained fall in LH and FSH secretion, dramatically reducing testosterone and estrogen synthesis, which is essential for controlling the targeted diseases.

The specific dose and dosing schedule of Leptoprol are determined by the prescribing clinician based on the patient’s condition, disease stage, and treatment goals. Only a qualified healthcare professional can set the appropriate regimen.

Leptoprol is contraindicated in pregnancy because it can affect fetal development by suppressing sex hormones. It is also not recommended while breastfeeding, as it may pass into breast milk and alter hormonal balance in the infant.

To request Leptoprol, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain where required) and import documentation.

Leptoprol (leuprorelin) is chemically similar to other GnRH agonists such as goserelin and triptorelin. All provide hormonal suppression, but differences may exist in dosing frequency, formulation stability, and approved indications. Clinicians choose based on patient convenience, pharmacokinetic profile, and specific regulatory approvals.

Leptoprol should be stored at 2‑8 °C in a refrigerator. Keep the vial in its original packaging, protect it from light, and avoid freezing or shaking the solution. Do not use the product if it has been exposed to temperatures outside this range.

Leptoprol is administered by subcutaneous injection, typically into the abdomen or thigh. The injection is performed by a healthcare professional or trained patient under sterile conditions, following the dosing schedule prescribed by the treating physician.

Serious risks include cardiovascular events such as hypertension or thrombosis, severe allergic reactions (anaphylaxis), significant loss of bone mineral density leading to osteoporosis, and rare pituitary apoplexy. Patients should be monitored regularly for these complications.

Leptoprol is contraindicated in pregnant women and should be used with caution in patients with pre‑existing cardiovascular disease, uncontrolled hypertension, severe osteoporosis, or known hypersensitivity to leuprorelin or any excipients in the formulation.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Leuprorelin

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT